This pathway drives the release of inflammatory mediators in GERD, and the inhibitory effects of ZJP reduce the production of TNF-α, IL-6, and IL-1β downstream of the MAPK/NF-κB signaling pathway, thereby attenuating the inflammatory response (21). This evidence concerns the gene IL6 and gastroesophageal reflux disease.